Page last updated: 2024-11-02

oxidopamine and Atrial Fibrillation

oxidopamine has been researched along with Atrial Fibrillation in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Korolev, DV1
Sonin, DL1
Medved, MS1
Shulmeister, GA1
Nikiforov, AI1
Murashova, LA1
Voronin, SE1
Mukhametdinova, DV1
Zaitseva, EA1
Mikhailov, EN1
Lebedev, DS1
Galagudza, MM1

Other Studies

1 other study available for oxidopamine and Atrial Fibrillation

ArticleYear
Acute Effect of Selective Chemical Inactivation of Sympathetic or Parasympathetic Atrial Ganglionated Plexus Structures on Atrial Fibrillation Inducibility in Pigs.
    Bulletin of experimental biology and medicine, 2022, Volume: 174, Issue:2

    Topics: Animals; Atrial Fibrillation; Heart Atria; Neurotransmitter Agents; Oxidopamine; Swine

2022